Using magnetic microgels to help regenerate limbs after amputation
Magnetic Microgels for Composite Musculoskeletal Tissue Regeneration
['FUNDING_R21'] · UNIVERSITY OF WASHINGTON · NIH-11116573
This study is exploring a new way to help people who have lost limbs by using tiny magnetic gels that can deliver healing proteins right where they need them, making it easier for bones and joints to grow back and improving recovery without needing lots of surgeries.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WASHINGTON (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11116573 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new method to help regenerate limbs in amputees by using specially designed magnetic microgels that can deliver growth factors directly to the site of amputation. The approach involves creating microgels that release proteins known to promote bone and joint formation, allowing for better healing and restoration of limb function. By applying a magnetic field, these microgels can be precisely controlled to release their contents at the right time and place, potentially improving the effectiveness of treatment. This innovative strategy aims to overcome the limitations of current methods that require multiple surgeries.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults who have experienced limb loss due to amputation.
Not a fit: Patients who have not undergone amputation or those with conditions that prevent participation in regenerative therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life for amputees by enhancing limb regeneration and function.
How similar studies have performed: Previous studies have shown promise in using growth factors for limb regeneration, but this specific approach using magnetic microgels is novel and has not been extensively tested.
Where this research is happening
SEATTLE, UNITED STATES
- UNIVERSITY OF WASHINGTON — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: QU, FEINI — UNIVERSITY OF WASHINGTON
- Study coordinator: QU, FEINI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.